William Blair & Company’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$159K Sell
10,306
-317
-3% -$4.9K ﹤0.01% 1455
2025
Q1
$158K Sell
10,623
-1,576
-13% -$23.4K ﹤0.01% 1437
2024
Q4
$162K Buy
12,199
+913
+8% +$12.1K ﹤0.01% 1477
2024
Q3
$160K Sell
11,286
-840
-7% -$11.9K ﹤0.01% 1476
2024
Q2
$157K Sell
12,126
-523
-4% -$6.77K ﹤0.01% 1452
2024
Q1
$176K Buy
12,649
+777
+7% +$10.8K ﹤0.01% 1427
2023
Q4
$169K Buy
11,872
+203
+2% +$2.9K ﹤0.01% 1426
2023
Q3
$181K Hold
11,669
﹤0.01% 1409
2023
Q2
$183K Sell
11,669
-55
-0.5% -$864 ﹤0.01% 1421
2023
Q1
$193K Sell
11,724
-55
-0.5% -$906 ﹤0.01% 1410
2022
Q4
$184K Buy
11,779
+3
+0% +$47 ﹤0.01% 1383
2022
Q3
$153K Buy
11,776
+782
+7% +$10.2K ﹤0.01% 1441
2022
Q2
$154K Sell
10,994
-1,031
-9% -$14.4K ﹤0.01% 1468
2022
Q1
$172K Buy
12,025
+390
+3% +$5.58K ﹤0.01% 1551
2021
Q4
$159K Sell
11,635
-1,287
-10% -$17.6K ﹤0.01% 1626
2021
Q3
$212K Buy
12,922
+96
+0.7% +$1.58K ﹤0.01% 1470
2021
Q2
$216K Sell
12,826
-423
-3% -$7.12K ﹤0.01% 1473
2021
Q1
$242K Buy
13,249
+336
+3% +$6.14K ﹤0.01% 1410
2020
Q4
$235K Sell
12,913
-1,445
-10% -$26.3K ﹤0.01% 1362
2020
Q3
$256K Sell
14,358
-534
-4% -$9.52K ﹤0.01% 1198
2020
Q2
$267K Buy
14,892
+880
+6% +$15.8K ﹤0.01% 1141
2020
Q1
$213K Buy
14,012
+524
+4% +$7.97K ﹤0.01% 1146
2019
Q4
$266K Sell
13,488
-3,556
-21% -$70.1K ﹤0.01% 1219
2019
Q3
$293K Buy
17,044
+1,660
+11% +$28.5K ﹤0.01% 1124
2019
Q2
$272K Sell
15,384
-806
-5% -$14.3K ﹤0.01% 1183
2019
Q1
$330K Buy
+16,190
New +$330K ﹤0.01% 1114